{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T23:50:44Z","timestamp":1795045844453,"version":"4.10.2"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,27]],"date-time":"2018-07-27T00:00:00Z","timestamp":1532649600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,7,27]],"date-time":"2018-07-27T00:00:00Z","timestamp":1532649600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Measurements of skeletal muscle cross-sectional area, index, and radiation attenuation utilizing clinical computed tomography (CT) scans are used in assessments of sarcopenia, the loss of skeletal muscle mass and function associated with aging. To classify individuals as sarcopenic, sex-specific cutoffs for \u2018low\u2019 values are used. Conventionally, cutoffs for skeletal muscle measurements at the level of the third lumbar (L3) vertebra are used, however L3 is not included in several clinical CT protocols. Non-contrast-enhanced CT scans from healthy kidney donor candidates (age 18\u201340) at Michigan Medicine were utilized. Skeletal muscle area (SMA), index (SMI), and mean attenuation (SMRA) were measured at each vertebral level between the tenth thoracic (T10) and the fifth lumbar (L5) vertebra. Sex-specific means, standard deviations (s.d.), and sarcopenia cutoffs (mean-2 s.d.) at each vertebral level were computed. Associations between vertebral levels were assessed using Pearson correlations and Tukey\u2019s difference test. Classification agreement between different vertebral level cutoffs was assessed using overall accuracy, specificity, and sensitivity. SMA, SMI, and SMRA L3 cutoffs for sarcopenia were 92.2 cm\n                    <jats:sup>2<\/jats:sup>\n                    , 34.4 cm\n                    <jats:sup>2<\/jats:sup>\n                    \/m\n                    <jats:sup>2<\/jats:sup>\n                    , and 34.3 HU in females, and 144.3 cm\n                    <jats:sup>2<\/jats:sup>\n                    , 45.4 cm\n                    <jats:sup>2<\/jats:sup>\n                    \/m\n                    <jats:sup>2<\/jats:sup>\n                    , and 38.5 HU in males, consistent with previously reported cutoffs. Correlations between all level pairs were statistically significant and high, ranging from 0.65 to 0.95 (SMA), 0.64 to 0.95 (SMI), and 0.63 to 0.95 (SMRA). SMA peaks at L3, supporting its use as the primary site for CT sarcopenia measurements. However, when L3 is not available alternative levels (in order of preference) are L2, L4, L5, L1, T12, T11, and T10. Healthy reference values reported here enable sarcopenia assessment and sex-specific standardization of SMA, SMI, and SMRA in clinical populations, including those whose CT protocols do not include L3.\n                  <\/jats:p>","DOI":"10.1038\/s41598-018-29825-5","type":"journal-article","created":{"date-parts":[[2018,7,23]],"date-time":"2018-07-23T07:03:02Z","timestamp":1532329382000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":477,"title":["Skeletal muscle cutoff values for sarcopenia diagnosis using T10 to L5 measurements in a healthy US population"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2869-9584","authenticated-orcid":false,"given":"Brian A.","family":"Derstine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven A.","family":"Holcombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian E.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas C.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace L.","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stewart C.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,27]]},"reference":[{"key":"29825_CR1","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.jand.2012.03.012","volume":"112","author":"JV White","year":"2012","unstructured":"White, J. V., Guenter, P., Jensen, G., Malone, A. & Schofield, M. Consensus statement of the academy of nutrition and dietetics\/american society for parenteral and enteral nutrition: characteristics recommended for the identification and documentation of adult malnutrition (undernutrition). Journal of the Academy of Nutrition and Dietetics 112, 730\u2013738 (2012).","journal-title":"Journal of the Academy of Nutrition and Dietetics"},{"key":"29825_CR2","doi-asserted-by":"publisher","unstructured":"Prado, C. M. et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 9, 629\u201335 https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18539529, https:\/\/doi.org\/10.1016\/s1470-2045(08)70153-0 (2008).","DOI":"10.1016\/s1470-2045(08)70153-0"},{"key":"29825_CR3","doi-asserted-by":"publisher","unstructured":"Prado, C. M. et al. Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res 15, 2920\u20136 http:\/\/clincancerres.aacrjournals.org\/content\/clincanres\/15\/8\/2920.full.pdf, https:\/\/doi.org\/10.1158\/1078-0432.ccr-08-2242 (2009).","DOI":"10.1158\/1078-0432.ccr-08-2242"},{"key":"29825_CR4","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","volume":"31","author":"L Martin","year":"2013","unstructured":"Martin, L. et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol 31, 1539\u201347, https:\/\/doi.org\/10.1200\/jco.2012.45.2722 (2013).","journal-title":"J Clin Oncol"},{"key":"29825_CR5","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1177\/0148607114550189","volume":"38","author":"CM Prado","year":"2014","unstructured":"Prado, C. M. & Heymsfield, S. B. Lean tissue imaging: a new era for nutritional assessment and intervention. JPEN J Parenter Enteral Nutr 38, 940\u201353, https:\/\/doi.org\/10.1177\/0148607114550189 (2014).","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"29825_CR6","doi-asserted-by":"publisher","first-page":"4445","DOI":"10.1245\/s10434-015-4558-4","volume":"22","author":"KW Reisinger","year":"2015","unstructured":"Reisinger, K. W. et al. Loss of skeletal muscle mass during neoadjuvant chemoradiotherapy predicts postoperative mortality in esophageal cancer surgery. Annals of surgical oncology 22, 4445\u20134452 (2015).","journal-title":"Annals of surgical oncology"},{"key":"29825_CR7","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1111\/ajt.13732","volume":"16","author":"J Vugt","year":"2016","unstructured":"Vugt, J. et al. Systematic review and meta-analysis of the impact of computed tomography\u2013assessed skeletal muscle mass on outcome in patients awaiting or undergoing liver transplantation. American Journal of Transplantation 16, 2277\u20132292 (2016).","journal-title":"American Journal of Transplantation"},{"key":"29825_CR8","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1158\/1078-0432.CCR-16-0940","volume":"23","author":"SS Shachar","year":"2017","unstructured":"Shachar, S. S. et al. Skeletal muscle measures as predictors of toxicity, hospitalization, and survival in patients with metastatic breast cancer receiving taxane-based chemotherapy. Clinical Cancer Research 23, 658\u2013665 (2017).","journal-title":"Clinical Cancer Research"},{"key":"29825_CR9","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/j.nut.2016.04.003","volume":"32","author":"Y Hamaguchi","year":"2016","unstructured":"Hamaguchi, Y. et al. Proposal for new diagnostic criteria for low skeletal muscle mass based on computed tomography imaging in asian adults. Nutrition 32, 1200\u20131205 (2016).","journal-title":"Nutrition"},{"key":"29825_CR10","unstructured":"Werf, A. et al. Percentiles for skeletal muscle index, area and radiation attenuation based on computed tomography imaging in a healthy caucasian population. European journal of clinical nutrition 1 (2017)."},{"key":"29825_CR11","doi-asserted-by":"publisher","unstructured":"Cruz-Jentoft, A. J. et al. Sarcopenia: European consensus on definition and diagnosis: Report of the european working group on sarcopenia in older people. Age Ageing 39, 412\u201323 http:\/\/ageing.oxfordjournals.org\/content\/39\/4\/412.full.pdf, https:\/\/doi.org\/10.1093\/ageing\/afq034 (2010).","DOI":"10.1093\/ageing\/afq034"},{"key":"29825_CR12","doi-asserted-by":"publisher","unstructured":"Studenski, S. A. et al. The fnih sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci 69, 547\u201358 https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24737557, https:\/\/doi.org\/10.1093\/gerona\/glu010 (2014).","DOI":"10.1093\/gerona\/glu010"},{"key":"29825_CR13","doi-asserted-by":"publisher","unstructured":"Chen, L. K. et al. Sarcopenia in asia: consensus report of the asian working group for sarcopenia. J Am Med Dir Assoc 15, 95\u2013101 https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24461239, https:\/\/doi.org\/10.1016\/j.jamda.2013.11.025 (2014).","DOI":"10.1016\/j.jamda.2013.11.025"},{"key":"29825_CR14","doi-asserted-by":"publisher","unstructured":"Fielding, R. A. et al. Sarcopenia: an undiagnosed condition in older adults. current consensus definition: prevalence, etiology, and consequences. international working group on sarcopenia. J Am Med Dir Assoc 12, 249\u201356 https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21527165, https:\/\/doi.org\/10.1016\/j.jamda.2011.01.003 (2011).","DOI":"10.1016\/j.jamda.2011.01.003"},{"key":"29825_CR15","doi-asserted-by":"crossref","unstructured":"Rosenberg, I. H. Sarcopenia: origins and clinical relevance. J Nutr 127, 990S\u2013991S https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9164280 (1997).","DOI":"10.1093\/jn\/127.5.990S"},{"key":"29825_CR16","doi-asserted-by":"crossref","unstructured":"Mitsiopoulos, N. et al. Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J Appl Physiol (1985) 85, 115\u201322 http:\/\/jap.physiology.org\/content\/jap\/85\/1\/115.full.pdf (1998).","DOI":"10.1152\/jappl.1998.85.1.115"},{"key":"29825_CR17","doi-asserted-by":"publisher","unstructured":"Shen, W. et al. Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image. J Appl Physiol (1985) 97, 2333\u20138 https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15310748, https:\/\/doi.org\/10.1152\/japplphysiol.00744.2004 (2004).","DOI":"10.1152\/japplphysiol.00744.2004"},{"key":"29825_CR18","doi-asserted-by":"publisher","unstructured":"Heymsfield, S. B., Adamek, M., Gonzalez, M. C., Jia, G. & Thomas, D. M. Assessing skeletal muscle mass: historical overview and state of the art. J Cachexia Sarcopenia Muscle 5, 9\u201318 https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3953319\/pdf\/13539_2014_Article_130.pdf, https:\/\/doi.org\/10.1007\/s13539-014-0130-5 (2014).","DOI":"10.1007\/s13539-014-0130-5"},{"key":"29825_CR19","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1139\/H08-075","volume":"33","author":"M Mourtzakis","year":"2008","unstructured":"Mourtzakis, M. et al. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab 33, 997\u20131006, https:\/\/doi.org\/10.1139\/h08-075 (2008).","journal-title":"Appl Physiol Nutr Metab"},{"key":"29825_CR20","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1152\/jappl.2000.89.1.104","volume":"89","author":"BH Goodpaster","year":"2000","unstructured":"Goodpaster, B. H., Kelley, D. E., Thaete, F. L., He, J. & Ross, R. Skeletal muscle attenuation determined by computed tomography is associated with skeletal muscle lipid content. Journal of applied physiology 89, 104\u2013110 (2000).","journal-title":"Journal of applied physiology"},{"key":"29825_CR21","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/apha.12224","volume":"210","author":"J Aubrey","year":"2014","unstructured":"Aubrey, J. et al. Measurement of skeletal muscle radiation attenuation and basis of its biological variation. Acta physiologica 210, 489\u2013497 (2014).","journal-title":"Acta physiologica"},{"key":"29825_CR22","doi-asserted-by":"crossref","first-page":"33658","DOI":"10.18632\/oncotarget.16866","volume":"8","author":"GR Williams","year":"2017","unstructured":"Williams, G. R. et al. Skeletal muscle measures and physical function in older adults with cancer: sarcopenia or myopenia? Oncotarget 8, 33658 (2017).","journal-title":"Oncotarget"},{"key":"29825_CR23","doi-asserted-by":"crossref","unstructured":"Derstine, B. A. et al. Quantifying sarcopenia reference values using lumbar and thoracic muscle areas in a healthy population. The journal of nutrition, health & aging 1\u20136 (2017).","DOI":"10.1007\/s12603-017-0983-3"},{"key":"29825_CR24","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.jgo.2015.08.005","volume":"6","author":"JR Broughman","year":"2015","unstructured":"Broughman, J. R. et al. Prevalence of sarcopenia in older patients with colorectal cancer. Journal of geriatric oncology 6, 442\u2013445 (2015).","journal-title":"Journal of geriatric oncology"},{"key":"29825_CR25","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/00031305.1994.10476059","volume":"48","author":"J Bring","year":"1994","unstructured":"Bring, J. How to standardize regression coefficients. The American Statistician 48, 209\u2013213 (1994).","journal-title":"The American Statistician"},{"key":"29825_CR26","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.bone.2003.10.001","volume":"34","author":"S Schuit","year":"2004","unstructured":"Schuit, S. et al. Fracture incidence and association with bone mineral density in elderly men and women: the rotterdam study. Bone 34, 195\u2013202 (2004).","journal-title":"Bone"},{"key":"29825_CR27","unstructured":"Werf, A. et al. Skeletal muscle analyses: agreement between non-contrast and contrast ct scan measurements of skeletal muscle area and mean muscle attenuation. Clinical Physiology and Functional Imaging (2017)."},{"key":"29825_CR28","unstructured":"Fuchs, G. et al. Quantifying the effect of slice thickness, intravenous contrast and tube current on muscle segmentation: Implications for body composition analysis. European radiology 1\u20139 (2018)."},{"key":"29825_CR29","doi-asserted-by":"publisher","unstructured":"Hanauer, D. A., Mei, Q., Law, J., Khanna, R. & Zheng, K. Supporting information retrieval from electronic health records: A report of university of michigan\u2019s nine-year experience in developing and using the electronic medical record search engine (emerse). J Biomed Inform 55, 290\u2013300 https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25979153, https:\/\/doi.org\/10.1016\/j.jbi.2015.05.003 (2015).","DOI":"10.1016\/j.jbi.2015.05.003"},{"key":"29825_CR30","unstructured":"Organization, W. H. Obesity: preventing and managing the global epidemic. 894 (World Health Organization, 2000)."},{"key":"29825_CR31","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1046\/j.1532-5415.2002.50216.x","volume":"50","author":"I Janssen","year":"2002","unstructured":"Janssen, I., Heymsfield, S. B. & Ross, R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. Journal of the American Geriatrics Society 50, 889\u2013896 (2002).","journal-title":"Journal of the American Geriatrics Society"},{"key":"29825_CR32","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s11606-011-1851-1","volume":"27","author":"RW Hingson","year":"2012","unstructured":"Hingson, R. W., Heeren, T., Edwards, E. M. & Saitz, R. Young adults at risk for excess alcohol consumption are often not asked or counseled about drinking alcohol. Journal of General Internal Medicine 27, 179\u2013184 (2012).","journal-title":"Journal of General Internal Medicine"},{"key":"29825_CR33","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1001\/jama.282.21.2012","volume":"282","author":"J Stamler","year":"1999","unstructured":"Stamler, J. et al. Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women. JAMA 282, 2012\u20132018 (1999).","journal-title":"JAMA"},{"key":"29825_CR34","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1001\/jama.295.13.1549","volume":"295","author":"CL Ogden","year":"2006","unstructured":"Ogden, C. L. et al. Prevalence of overweight and obesity in the united states, 1999\u20132004. JAMA 295, 1549\u20131555 (2006).","journal-title":"JAMA"},{"key":"29825_CR35","doi-asserted-by":"publisher","first-page":"e492","DOI":"10.1200\/JCO.2011.35.5602","volume":"29","author":"AM Geiger","year":"2011","unstructured":"Geiger, A. M. & Castellino, S. M. Delineating the age ranges used to define adolescents and young adults. Journal of Clinical Oncology 29, e492\u2013e493 (2011).","journal-title":"Journal of Clinical Oncology"},{"key":"29825_CR36","doi-asserted-by":"publisher","unstructured":"Krishnamurthy, V. et al. Use of analytic morphomics of liver, spleen, and body composition to identify patients at risk for cirrhosis. Clin Gastroenterol Hepatol 13, 360\u2013368 e5 https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25083565, https:\/\/doi.org\/10.1016\/j.cgh.2014.07.042 (2015).","DOI":"10.1016\/j.cgh.2014.07.042"},{"key":"29825_CR37","doi-asserted-by":"publisher","unstructured":"Heymsfield, S. B., Heo, M., Thomas, D. & Pietrobelli, A. Scaling of body composition to height: relevance to height-normalized indexes. Am J Clin Nutr 93, 736\u201340 https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21248190, https:\/\/doi.org\/10.3945\/ajcn.110.007161 (2011).","DOI":"10.3945\/ajcn.110.007161"},{"key":"29825_CR38","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1152\/jappl.2001.90.6.2157","volume":"90","author":"BH Goodpaster","year":"2001","unstructured":"Goodpaster, B. H. et al. Attenuation of skeletal muscle and strength in the elderly: The health abc study. Journal of applied physiology 90, 2157\u20132165 (2001).","journal-title":"Journal of applied physiology"},{"key":"29825_CR39","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.2214\/AJR.16.16387","volume":"207","author":"RD Boutin","year":"2016","unstructured":"Boutin, R. D., Kaptuch, J. M., Bateni, C. P., Chalfant, J. S. & Yao, L. Influence of iv contrast administration on ct measures of muscle and bone attenuation: Implications for sarcopenia and osteoporosis evaluation. American Journal of Roentgenology 207, 1046\u20131054 (2016).","journal-title":"American Journal of Roentgenology"},{"key":"29825_CR40","unstructured":"Rupert, G. Jr. et al. Simultaneous statistical inference (Springer Science & Business Media, 2012)."},{"key":"29825_CR41","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria https:\/\/www.R-project.org\/ (2016)."},{"key":"29825_CR42","doi-asserted-by":"crossref","unstructured":"Wickham, H. ggplot2: Elegant Graphics for Data Analysis http:\/\/ggplot2.org (Springer-Verlag New York, 2009).","DOI":"10.1007\/978-0-387-98141-3"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-29825-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-29825-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-29825-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T10:36:50Z","timestamp":1720435010000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-29825-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,27]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["29825"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-29825-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,27]]},"assertion":[{"value":"5 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Brian A. Derstine, Brian E. Ross, Nicholas C. Wang, and Grace L. Su declare that they have no conflict of interest. Sven A. Holcombe and Stewart C. Wang are listed as inventors on a US Patent for Analytic Morphomics (#US 20140064583 A1).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"11369"}}